Background: Polycystic ovarian syndrome (PCOS) is the most common condition among reproductive-aged women. However, its exact prevalence is unknown.
INTRODUCTION
Polycystic ovarian syndrome (PCOS) is the most common endocrine abnormality in reproductive-aged women.
1 A great deal of research has been devoted to unravelling the complexities of PCOS and its diagnosis, treatment and complications. 2 However, there is still a gap in the literature relating to the prevalence of PCOS globally and in Australia. This uncertainty exists because different criteria are used to determine this prevalence estimate. [3] [4] [5] Furthermore, the physical and psychological impact of a diagnosis of PCOS in young women is yet to be elucidated.
Three sets of criteria have been created for the diagnosis of PCOS. [3] [4] [5] These are the National Institutes of Health (NIH) criteria (1992), 3 Rotterdam criteria (2003) 4 and Androgen Excess Society (AES) criteria (2006) 5 (Table 1 ). These criteria comprise oligo/ anovulation, clinical or biochemical hyperandrogenism and polycystic ovaries on transvaginal ultrasound, in various combinations. None of these sets of criteria have been implemented as the gold standard due to controversy over which criteria should be included. 6 Furthermore, these criteria are less applicable to adolescents as individual components of the criteria overlap with normal physiological changes of puberty and therefore cannot be considered as pathological changes of PCOS.
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There also are increased healthcare costs due to treatment and associated complications of PCOS. 1 These complications include reproductive health issues, obesity, insulin resistance, hypertension, cardiovascular disease and mood disorders. 7, 8 These wide range of potential complications can result in women feeling burdened by PCOS, contributing to a reduced quality of life.
9
In this paper, we describe a sub-study of the Young Female Health Initiative (YFHI) and Safe-D studies. YFHI and Safe-D are comprehensive health and lifestyle studies of young Australian women (aged 16-29 years) recruited via Facebook advertising.
10
The first aim of this sub-study was to determine the prevalence of PCOS in this population using the NIH criteria. The second aim was to examine differences in comorbidities between those who self-reported PCOS and those who did not self-report PCOS, and between those who fulfilled the NIH criteria for PCOS and those who did not fulfil the criteria. It is important to note that self-reported PCOS does not indicate a confirmed diagnosis of PCOS. It refers to responses provided by participants to our questionnaire. Finally, we also investigated which aspects of this condition were particularly distressing to those with selfreported PCOS.
MATERIALS AND METHODS

Ethics
The YFHI and Safe-D studies were approved by the Human 
Clinical measurements
After completing the original survey, participants were invited to a site visit to measure weight and height using beam balance 
Definitions
PCOS
To meet the NIH definition 3 of PCOS, participants needed to exhibit both oligo/anovulation (based on length and regularity of cycles) and biochemical (testosterone) or clinical (acne, hirsutism and androgenic alopecia) hyperandrogenism.
Oligo/anovulation
Oligo/anovulation was defined as average cycle length <21 days or >35 days, or <8 cycles per year, 3 without taking hormonal contraception.
Biochemical and clinical hyperandrogenism
Clinical hyperandrogenism was hirsutism (Ferriman-Gallwey (F-G) 
Pregnancies
A history of pregnancy, regardless of outcome.
Exclusion criteria
Participants were excluded if thyroid stimulating hormone (TSH) 
RESULTS
Study population
Baseline data were collected for 655 participants (Fig. 1 ). Of these, 490 (75%) consented to future studies and hence were eligible for this sub-study of whom, 308/490 (63%) agreed to participate. After 8/308 (3%) were excluded due to abnormal blood tests, 300/308 (97%) remained. With regards to diagnostic criteria, 48/300 (16%)
reported menstrual irregularity in the preceding 12 months.
Hirsutism was present in 75/300 (25%), acne was reported in 184/300 (61%) and 36/300 (12%) reported androgenic alopecia.
Prevalence of PCOS according to the NIH criteria and according to self-report
To determine the prevalence of PCOS by NIH criteria, we excluded participants who responded 'unsure' or 'not applicable' 
Differences between participants who fulfilled NIH criteria and those who did not fulfil criteria
When comparing comorbidities, only the presence of acne was significantly greater in those who fulfilled the NIH criteria (n = 254, 84% vs 57%, P = 0.005) compared to those who did not.
There were no other statistically significant differences in demographic or metabolic risk factors between the groups (Table 2 ).
Differences between participants who self-reported PCOS and those who did not self-report PCOS
There were no significant differences in demographics between those who self-reported PCOS and those who did not (Table 3) ; P-value <0.05 was determined statistically significant. ‡Missing data. §Based on postal area code. Deciles are rankings within Victoria, Australia. The lowest 10% of areas are assigned a decile number of 1 and the highest 10% of areas are given a decile number of 10. Decile 1 is the most disadvantaged relative to the other deciles. ¶Excluded participants who did not fast at time of blood test. † †Excluded two participants as it is unknown if participant had fasted. ‡ ‡Only used participants age >18 years as a greater number of younger participants (16-17 years) were recruited in Safe-D study than YFHI study. BMI, body mass index; DHEAS, dehydroepiandrosterone; F-G score, Ferriman-Gallwey Score; G:I, glucose to insulin; HDL, high density lipoprotein; LDL, low density lipoprotein; PCOS, polycystic ovarian syndrome; Seifa, Socio-Economic Indexes for Areas; SHBG, sex hormone binding globulin; WH, waist-hip; YFHI, Young Female Health Initiative. Interquartile range (IQR) is quartile 1 (25th percentile) to quartile 3 (75th percentile). *p-value<= 0.05 (6.0-10.3), P = 0.03). They also were more likely to self-report a history of depression (n = 300, 52% vs 26% P = 0.006), history of pregnancy (n = 222, 26% vs 7%, P = 0.01) and a history of miscarriage (n = 13, 100% vs 22%, P = 0.02). Using multivariable logistic regression analyses, we found that self-reported PCOS was positively associated with reported depression and a history of pregnancy (Table 4 ).
Differences between participants who selfreported PCOS and those who did not self-report PCOS if they met the NIH criteria (n = 31)
Among the 31 participants who fulfilled the NIH criteria for PCOS, 8/31 (26%) self-reported PCOS and 23/31 (74%) did not. When comparing these two groups, there were significant differences in current contraceptive use (88% vs 30%, P = 0.01), fasting G:I (glucose : insulin) ratio (4.9 (0.9-6.0) vs 10.0 (7.8-15.4), P = 0.02) and measured hypertension (38% vs 5%, P = 0.05; Table 5 ).
Qualitative analysis on the impact of self-reported PCOS on wellbeing
Among those who self-reported PCOS, 65% ( †P-values were determined using Fisher's exact, χ 2 or Mann-Whitney U-test; P-value < 0.05 was determined statistically significant. ‡Missing data, values may not add up to 100%. §Based on postal area code. Deciles are rankings within Victoria, Australia. The lowest 10% areas are assigned a decile number of 1 and the highest 10% of areas are given a decile number of 10. Decile 1 is the most disadvantaged relative to the other deciles. ¶Excluded participants who did not fast at time of blood test. † †Excluded three participants as it is unknown whether participant had fasted. ‡ ‡Only used participants age >18 years as a greater number of younger participants (16-17 years) were recruited in Safe-D study than YFHI study. BMI, body mass index; DHEAS, dehydroepiandrosterone; F-G score, Ferriman-Gallwey Score; G:I, glucose to insulin; HDL, high density lipoprotein; LDL, low density lipoprotein; PCOS, polycystic ovarian syndrome; Seifa, Socio-Economic Indexes for Areas; SHBG, sex hormone binding globulin; WH, waist-hip; YFHI, Young Female Health Initiative. Interquartile range (IQR) is quartile 1 (25th percentile) to quartile 3 (75th percentile). *p-value<= 0.05
TABLE 3 (Continued)
that I can't fall pregnant without medication', 'concerned it will be difficult' and 'I've had miscarriages before so I wonder if PCOS has anything to do with it. It is emotionally exhausting to think about'.
We asked participants to make some general comments about their experience with PCOS. Some examples included 'was a very long time trying to conceive which was depressing but eventually happened', 'I thought my fertility was sub average -but I have conceived very easily twice', 'I have learnt the hard way that not all women are as infertile as they might be told' and 'Although doctors have said that it's very unlikely that I'll become pregnant without intervention, I'm currently 34 weeks pregnant with no fertility assistance. I think doctors should be careful of the information they provide to clients as this diagnosis caused me a lot of depression and anxiety'.
DISCUSSION
Using the NIH criteria, the prevalence of PCOS in our cohort of young females aged 16-29 was 12%. There were more comorbidities in those with self-reported PCOS than those without self-reported PCOS, and the most concerning aspect for participants with a diagnosis of PCOS was the possibility of infertility.
Our prevalence estimate was greater than determined by The difference in prevalence estimates can be partly attributed to the way the diagnostic criteria are applied. 21 Some researchers have published narrower cut-offs for oligo/anovulation, with only ≥35 days 20 or only ≤8 cycles per year. 17 We determined clinical hyperandrogenism on self-reported acne, which was common, thus potentially increasing the diagnosis of PCOS in our cohort; hirsutism, which was subjectively assessed and could have been over-or underestimated; and self-reported androgenic alopecia, which was not assessed in many previous studies. [17] [18] [19] [20] For testosterone, the 95th percentile of the non-PCOS group was often the cut-off. However, this value differed greatly between papers (range 2.4 nmol/L 17 -4.5 nmol/L 19 ). In our study, the 95th percentile was lower than this range (2.2 nmol/L), potentially increasing the number of participants who fulfilled the criteria. Therefore, we recommend the development of standardised criteria with set parameters that allow comparison between populations. Furthermore, diagnosing adolescents with PCOS is challenging because symptoms overlap with normal pubertal development. 21 Consequently, there is a greater probability of incorrect diagnosis.
There were no differences in comorbidities in women of this age, whether they met the NIH criteria or not (Table 2) . While there appeared to be some differences on those diagnosed by self-report versus those not diagnosed, the psychological comorbidity appeared to be significant in those who self-reported a diagnosis (Table 3) . Thus, correct diagnosis of PCOS and the way it is conveyed to young women is critical to their mental and physical wellbeing.
We discovered that the three most common reactions to a diagnosis of PCOS were 'unhappy or worried', 'scared' and 'confused'. Those confused about the diagnosis reported that doctors did not explain PCOS properly. Similarly, Trent et al. 22 determined that more than 50% of adolescent girls described PCOS negatively, despite only a fraction understanding their illness. In our study, 72% (13/18) claimed fear of infertility was the most distressing aspect of PCOS, a similar result to other papers. 22 Menstrual dysfunction 23, 24 and hirsutism 23, 24 were also implicated, but possible infertility was the most common feature that reduced healthrelated quality of life 9 .
In our study, over 50% in the self-reported PCOS group were afraid they could not have children. Despite pregnancy rates being higher in this group ( discussions about fertility concerns are important parts of managing PCOS. 25 These concerns should not be neglected because of age as these concerns appear to rise as early as adolescence. 25 To the best of our knowledge, this is the only Australian study of PCOS in which young adult women, a population underrepresented in the literature, were recruited. This was an important group to consider as major health and lifestyle decisions are made at this age. Additionally, our sample was representative of 16-29-year-olds in Australia when compared with demographics from the Australian census data.
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There were some methodological limitations to this study.
First, we applied one of three established sets of criteria (NIH) to diagnose PCOS as the other two criteria (Rotterdam and AES) require transvaginal ultrasound, to which we did not have access for this study. Second, site visits for five participants were completed up to four years before the supplementary questionnaire was answered. Therefore, these anthropometric data may not be reflective of a participant's current body composition. Additionally, self-reported PCOS was not confirmed with medical records.
Serum androgen levels were available in most (84%) but not all †P-values were determined using Fisher's exact, χ 2 or Mann-Whitney U-test; P-value <0.05 was determined statistically significant. ‡Missing data, values may not add up to 100%. §Based on postal area code. Deciles are rankings within Victoria, Australia. The lowest 10% areas are assigned a decile number of 1 and the highest 10% of areas are given a decile number of 10. Decile 1 is the most disadvantaged relative to the other deciles. ¶Excluded participants who did not fast at time of blood test. † †Excluded three participants as it is unknown whether participant had fasted. ‡ ‡Only used participants age >18 years as a greater number of younger participants (16-17 years) were recruited in Safe-D study than YFHI study. BMI, body mass index; DHEAS, dehydroepiandrosterone; F-G score, Ferriman-Gallwey Score; G:I, glucose to insulin; HDL, high density lipoprotein; LDL, low density lipoprotein; PCOS, polycystic ovarian syndrome; Seifa, Socio-Economic Indexes for Areas; SHBG, sex hormone binding globulin; WH, waist-hip; YFHI, Young Female Health Initiative. Interquartile range (IQR) is quartile 1 (25th percentile) to quartile 3 (75th percentile). *p-value<= 0.05
TABLE 5 (Continued)
participants, limiting the utility of applying the NIH diagnostic criteria. Finally, we had a relatively small sample size compared to other prevalence studies. With a larger sample size, we may have more power to detect significant associations.
In conclusion, the prevalence of PCOS in this sample using NIH criteria was 12%. There is a great deal of variability in diagnostic criteria between studies, which makes it difficult to calculate and compare prevalence values. This is important for clinicians to recognise as they may be potentially over-diagnosing PCOS in young women, contributing to unnecessary and unwarranted fears of complications, particularly infertility.
